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The term “stem sell” ﬁrst appeared in scientiﬁc literature in
1868, when the German scientist Ernst Haeckel merged the
concepts of phylogeny and ontogeny to describe the “stammzelle” (stem cell), an evolutionary concept of a primordial cell
that evolves into all cells and multicellular organisms [1].
Although Haeckel’s argument and use of the term “stem cell”
nearly 150 years ago were impressive, they were based on his
observations of embryo development and the distinction
between fertilized and nonfertilized eggs. The ﬁrst deﬁnitive
evidence for the existence of stem cells came in the early
1960s, after the Canadian scientists Ernest McCulloch and
James Till performed experiments on the bone marrow of
mice and observed that diﬀerent blood cells come from a special class of cells [2]. Stem cell research has progressed rapidly
since 1981, when the British scientist Martin Evans and the
American scientist Gail Martin succeeded in isolating and
culturing mice embryonic stem cells (ESCs). In the late
1990s, American scientist James Thomson ﬁrst isolated
human ESCs, revealing the potential for a pluripotent stem
cell that would be a source of various germ layers and new
organs [3]. Arguably, this recognition of the pluripotency of
human stem cells triggered the exponential developments
in stem cell research seen over the last two decades. Regenerative medicine has emerged as a new discipline, and its

principles have been extended to surgical and nonsurgical
specialties in medicine.
As a surgical specialty covering the pathologies of tissues
and organs derived from two diﬀerent germ layers, including
the mesoderm (bone, cartilage, muscle, and ligaments) and
the ectoderm (spinal cord and nerves), orthopaedic surgery
is arguably one of the disciplines in which stem cell-based
therapeutic strategies can be applied the most diversely.
This special issue is aimed at presenting and discussing
the current concepts and groundbreaking developments in
stem cell-based treatment strategies in the ﬁeld of orthopaedic surgery. Since adipose tissue is easier to retrieve and can
often be harvested in ample quantities, K. Kjaergaard et al.
studied the in vivo osteogenic potential of adipose-derived
culture-expanded stem cells in an animal model. The authors
showed that adipose-derived cells were capable of forming
new bone, although their potential was signiﬁcantly lower
than that of stem cells derived from bone marrow. C. L.
Roberts et al. aimed to answer the question of whether
human osteoblasts can be reverted to the pluripotent embryonic state. Their results demonstrated that pluripotent stem
cells that are reverse induced from osteoblasts are capable
of generating osteogenic and chondrogenic cells, but lack
the ability to form adipocytes.
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N. Kamei et al. reviewed endothelial progenitor cells
(EPCs) as a promising source of cell-based therapies to
regenerate musculoskeletal and neural tissues. B. D. Bates
et al. demonstrated the potential of EPCs to enhance the
radiographic and morphometric parameters of bone healing
when applied three weeks after bony injury in a rat model
of delayed fracture healing.
Stem cell-based therapeutic applications have become the
focusofintensiveresearchinthetreatmentofdegenerativejoint
pathologies, including osteoarthritis and degenerative disc disease(DDD)[4].H.Madryetal.contributedareviewarticletothis
specialissuethatsummarizesthetechnical,clinical,andbiological aspects of using bone marrow aspirate concentrate with
mesenchymalstemcells(MSCs)torepairandregenerateosteochondral defects. Furthermore, to enhance structure-speciﬁc
regeneration of hyaline cartilage in a rabbit model, W. Guo
et al. loaded MSCs onto a composite scaﬀold that mimicked the
alignedconﬁgurationofnativecartilagetissue.Inanotherinteresting study from Japan, E. E. Mahmoud et al. investigated the
therapeutic potential of human multilineage diﬀerentiating
stress-enduring cells for repairing osteochondral defects in an
immuno-deﬁcient rat model.
Stem cell-based therapies for DDD still struggle with
challenges, including the detrimental eﬀects of the hypoxic,
inﬂammatory microenvironment of intervertebral discs,
which reduces the activity and vitality of transplanted stem
cells [4]. Realizing these challenges, W. Wang et al. investigated the eﬀects of hypoxic preconditioned bone MSCs on
repairing and regenerating intervertebral discs in a rat
DDD model.
The anterior cruciate ligament (ACL) and rotator cuﬀ
(RC) are among the most frequently encountered ligament/
tendon injuries in orthopaedic clinical practice [5]. However,
the potential of the ACL and RC to self-regenerate and
heal is recognized as extremely poor [6]. In a review article, K. J. Lee et al. summarized critical aspects of current
research, focusing on the use of ligament-derived stem
cells as a regenerative treatment strategy for patients with
tendon/ligament pathologies.
In the ﬁeld of regenerative medicine in general and in the
use of stem cell-based therapeutic strategies in orthopaedic
surgery in particular, one of the most pressing issues is to
translate the enormous quantity of research into clinical
practice. Despite the ever-increasing global activity and an
accumulating body of literature, very few cell-based therapies
for musculoskeletal disorders have been eﬀectively translated
into clinical practice [7, 8]. The foundation for solving this
translation conundrum will be provided by orthopaedic
surgeon-scientists with in-depth understanding of basic and
clinical research principles. With this in mind, we gathered
a guest editorial team from among the most prominent
orthopaedic surgeon-scientists around the world who were
willing to exercise particular attention to promote clinical
research papers in this special issue. One such paper, by D.
Granchi et al., investigated changes in biochemical bone
turnover markers according to the progression of bone healing induced by autologous MSCs combined with biphasic
calcium phosphate in patients having delayed union or nonunion of long bone fractures. Finally, the issue includes a
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multicentric randomized clinical trial protocol from E.
Gómez-Barrena et al. and investigators from centers in Italy,
Germany, France, and Spain, who aim to compare the eﬃcacy of treatment with autologous human bone marrowderived mesenchymal stromal cells versus iliac crest autograft
to enhance bone healing in patients with diaphyseal and/or
metaphysodiaphyseal fractures (femur, tibia, and humerus)
that had statuses of atrophic or oligotrophic nonunion.
We hope that this special issue, “Developing Stem
Cell-based Therapeutic Strategies in Orthopaedic Surgery,”
will help the scientiﬁc community ﬁnd answers to some of
its questions and will make a few strides toward beneﬁtting
our patients.
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